How should the war on drugs be fought? Everyone seems to agree that the United States ought to use a combination of several different approaches to combat the destructive effects of illegal drug use. Yet there is a remarkable paucity of data and research information that policy makers require if they are to create a useful, realistic policy package-details about drug use, drug market economics, and perhaps most importantly the impact of drug enforcement activities. Informing America's Policy on Illegal Drugs recommends ways to close these gaps in our understanding-by obtaining the necessary data on drug prices and consumption (quantity in addition to frequency); upgrading federal management of drug statistics; and improving our evaluation of prevention, interdiction, enforcement, and treatment efforts. The committee reviews what we do and do not know about illegal drugs and how data are assembled and used by federal agencies. The book explores the data and research information needed to support strong drug policy analysis, describes the best methods to use, explains how to avoid misleading conclusions, and outlines strategies for increasing access to data. Informing America's Policy on Illegal Drugs also discusses how researchers can incorporate randomization into studies of drug treatment and how state and local agencies can compare alternative approaches to drug enforcement. Charting a course toward a better-informed illegal drugs policy, this book will be important to federal and state policy makers, regulators, researchers, program administrators, enforcement officials, journalists, and advocates concerned about illegal drug use. Table of ContentsFront MatterExecutive Summary1 Introduction2 Determinants and Consequences of Drug Use3 Data Needs for Monitoring Drug Problems4 Drug Data Organization5 Supply-Reduction Policy6 Sanctions against Users of Illegal Drugs7 Preventing Drug Use8 Treatment of Drug Users9 Final Thoughts: Unfinished BusinessAppendix A: Characteristics of STRIDE Cocaine DataAppendix B: Data SourcesAppendix C: Phase I Report Executive SummaryAppendix D: How Do Response Problems Affect Survey Measurement of Trends in Drug Use?Appendix E: Linking Treatment to Punishment: An Evaluation of Drug Treatment in the Criminal Justice SystemAppendix F: Biographical SketchesIndex
Les mer
Recommends ways to close gaps in our understanding - by obtaining the necessary data on drug prices and consumption (quantity in addition to frequency); upgrading federal management of drug statistics; and improving our evaluation of prevention, interdiction, enforcement, and treatment efforts.
Les mer
1 Front Matter; 2 Executive Summary; 3 1 Introduction; 4 2 Determinants and Consequences of Drug Use; 5 3 Data Needs for Monitoring Drug Problems; 6 4 Drug Data Organization; 7 5 Supply-Reduction Policy; 8 6 Sanctions against Users of Illegal Drugs; 9 7 Preventing Drug Use; 10 8 Treatment of Drug Users; 11 9 Final Thoughts: Unfinished Business; 12 Appendix A: Characteristics of STRIDE Cocaine Data; 13 Appendix B: Data Sources; 14 Appendix C: Phase I Report Executive Summary; 15 Appendix D: How Do Response Problems Affect Survey Measurement of Trends in Drug Use?; 16 Appendix E: Linking Treatment to Punishment: An Evaluation of Drug Treatment in the Criminal Justice System; 17 Appendix F: Biographical Sketches; 18 Index
Les mer

Produktdetaljer

ISBN
9780309072731
Publisert
2001-10-27
Utgiver
Vendor
National Academies Press
Høyde
229 mm
Bredde
152 mm
Aldersnivå
P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet
Antall sider
423

Biographical note

Committee on Data and Research for Policy on Illegal Drugs, Charles F. Manski, John V. Pepper, and Carol V. Petrie, Editors, Committee on Law and Justice and Committee on National Statistics, National Research Council